MODERATOR
:
Karen E. King, MD, Medical Director, Hemapheresis/Transfusion Support, Johns Hopkins
SPEAKER
(S):
Karen E. King, MD, Medical Director, Hemapheresis/Transfusion Support, Johns Hopkins
The role of therapeutic plasma exchange in incompatible kidney transplantation
Marisa Marques, MD, Professor, University of Alabama at Birmingham
Therapeutic apheresis in heart transplant rejection
Dr. Michael Linenberger, MD, Medical Director, Apheresis & Cellular Therapy, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Apheresis for patients undergoing stem cell transplantation
Description
Recently, therapeutic apheresis has experienced an expanding role in the care of patients undergoing various types of transplantation. Apheresis is being used in preparative regimens and as treatment for transplant-related complications, including rejection and graft-vs- host disease. This session will highlight recent advances in the field, focusing on the role of apheresis in caring for patients with incompatible kidney transplants, heart transplants and peripheral blood stem cell transplants. The indications for therapeutic plasma exchange and photopheresis will be discussed.
-
Describe the role of therapeutic plasma exchange in supporting ABO and HLA incompatible kidney transplant patients.
-
Discuss the experience with therapeutic apheresis in heart transplant rejection.
-
Review the use of apheresis for patients undergoing stem cell transplantation.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.